非流感RNA呼吸道病毒的全球流行病学:数据缺口与日益增长的监测需求
本文为Lancet Infect Dis的个人观点文章,指出非流感RNA呼吸道病毒(NIRV)与流感一样构成全球健康负担,但其全球遗传多样性数据远少于流感,阻碍抗病毒药物和疫苗的研发与许可。作者呼吁扩大NIRV基因数据库并增加该领域研究投入,以支持新药和疫苗开发及新发疾病准备。
要点
- NIRV包括呼吸道合胞病毒、副流感病毒、冠状病毒、鼻病毒和人类偏肺病毒,全球健康负担显著。
- NIRV全球遗传多样性数据稀缺,是抗病毒药物和疫苗许可的主要知识缺口和障碍。
- 加强基因监测有助于NIRV药物疫苗研发,也是新发疾病准备的一部分。
核心结论
- 非流感RNA呼吸道病毒的全球遗传数据稀缺构成重大知识缺口,阻碍抗病毒药物和疫苗的许可。
- 加强基因监测可促进NIRV新药和疫苗研发,并支持新发疾病准备。
研究设计与样本
- 本文为个人观点文章,未报告系统检索范围或样本量。
主要发现
- 与流感病毒相比,非流感RNA呼吸道病毒的全球 contemporaneous 多样性知之甚少。
- 多种NIRV的抗病毒药物和疫苗处于不同研发阶段,但尚无干预措施获批。
- 非人冠状病毒和副粘病毒被列入WHO近期新发传染病研发蓝图优先关注事项。
临床怎么用
- 临床和公共卫生层面应重视扩大NIRV基因数据库并增加研究投入。
- 理解呼吸道病毒全球多样性有助于新发疾病准备。
局限性
- 本文为个人观点文章,未提供原始研究数据或系统分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Together with influenza, the non-influenza RNA respiratory viruses (NIRVs), which include respiratory syncytial virus, parainfluenza viruses, coronavirus, rhinovirus, and human metapneumovirus, represent a considerable global health burden, as recognised by WHO's Battle against Respiratory Viruses initiative. By contrast with influenza viruses, little is known about the contemporaneous global diversity of these viruses, and the relevance of such for development of pharmaceutical interventions. Although far less advanced than for influenza, antiviral drugs and vaccines are in different stages of development for several of these viruses, but no interventions have been licensed. This scarcity of global genetic data represents a substantial knowledge gap and impediment to the eventual licensing of new antiviral drugs and vaccines for NIRVs. Enhanced genetic surveillance will assist and boost research and development into new antiviral drugs and vaccines for these viruses. Additionally, understanding the global diversity of respiratory viruses is also part of emerging disease preparedness, because non-human coronaviruses and paramyxoviruses have been listed as priority concerns in a recent WHO research and development blueprint initiative for emerging infectious diseases. In this Personal View, we explain further the rationale for expanding the genetic database of NIRVs and emphasise the need for greater investment in this area of research.
引用
- Tang JW, Lam TT, Zaraket H, et al. Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance. Lancet Infect Dis. 2017. PMID: 28457597. doi:10.1016/S1473-3099(17)30238-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。